Eton Pharmaceuticals licenses topical gel ASN-001 for infantile hemangiomas

August 5, 2026 6:50 AM

Eton Pharmaceuticals (NASDAQ: ETON) has licensed U.S. rights to ASN-001, a timolol topical gel under development for proliferating superficial infantile ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found